These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 25605455)
1. Getting the best out of thiopurine therapy: thiopurine S-methyltransferase and beyond. Fong SC; Blaker PA; Arenas-Hernandez M; Marinaki AM; Sanderson JD Biomark Med; 2015; 9(1):51-65. PubMed ID: 25605455 [TBL] [Abstract][Full Text] [Related]
2. [Optimized thiopurine treatment in chronic inflammatory bowel disease]. Kiszka-Kanowitz M; Theede K; Nielsen AM Ugeskr Laeger; 2015 Jun; 177(26):1253-5. PubMed ID: 26550625 [TBL] [Abstract][Full Text] [Related]
3. Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease. Kwan LY; Devlin SM; Mirocha JM; Papadakis KA Dig Liver Dis; 2008 Jun; 40(6):425-32. PubMed ID: 18304898 [TBL] [Abstract][Full Text] [Related]
4. Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease. Chouchana L; Narjoz C; Beaune P; Loriot MA; Roblin X Aliment Pharmacol Ther; 2012 Jan; 35(1):15-36. PubMed ID: 22050052 [TBL] [Abstract][Full Text] [Related]
5. The role of thiopurine metabolite monitoring in inflammatory bowel disease. Beswick L; Friedman AB; Sparrow MP Expert Rev Gastroenterol Hepatol; 2014 May; 8(4):383-92. PubMed ID: 24684593 [TBL] [Abstract][Full Text] [Related]
6. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease. Gearry RB; Barclay ML J Gastroenterol Hepatol; 2005 Aug; 20(8):1149-57. PubMed ID: 16048561 [TBL] [Abstract][Full Text] [Related]
7. Allopurinol enhanced thiopurine treatment for inflammatory bowel disease: safety considerations and guidelines for use. Min MX; Weinberg DI; McCabe RP J Clin Pharm Ther; 2014 Apr; 39(2):107-11. PubMed ID: 24438369 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic drug monitoring of thiopurine metabolites in adult thiopurine tolerant IBD patients on maintenance therapy. Gilissen LP; Wong DR; Engels LG; Bierau J; Bakker JA; Paulussen AD; Romberg-Camps MJ; Stronkhorst A; Bus P; Bos LP; Hooymans PM; Stockbrügger RW; Neef C; Masclee AA J Crohns Colitis; 2012 Jul; 6(6):698-707. PubMed ID: 22398098 [TBL] [Abstract][Full Text] [Related]
9. Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD. Seidman EG Rev Gastroenterol Disord; 2003; 3 Suppl 1():S30-8. PubMed ID: 12684587 [TBL] [Abstract][Full Text] [Related]
10. [Optimized thiopurine treatment in chronic inflammatory bowel disease]. Kiszka-Kanowitz M; Theede K; Nielsen AM Ugeskr Laeger; 2014 May; 176(22):. PubMed ID: 25352005 [TBL] [Abstract][Full Text] [Related]
11. Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease? Fangbin Z; Xiang G; Minhu C; Liang D; Feng X; Min H; Pinjin H Ther Drug Monit; 2012 Dec; 34(6):695-701. PubMed ID: 23149442 [TBL] [Abstract][Full Text] [Related]
13. Usefulness of thiopurine methyltransferase and thiopurine metabolite analysis in clinical practice in patients with inflammatory bowel diseases. Dewit O Acta Gastroenterol Belg; 2010; 73(3):331-5. PubMed ID: 21086934 [TBL] [Abstract][Full Text] [Related]
14. Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations. Al Hadithy AF; de Boer NK; Derijks LJ; Escher JC; Mulder CJ; Brouwers JR Dig Liver Dis; 2005 Apr; 37(4):282-97. PubMed ID: 15788214 [TBL] [Abstract][Full Text] [Related]
15. Thiopurine therapy in inflammatory bowel disease. Ha C; Dassopoulos T Expert Rev Gastroenterol Hepatol; 2010 Oct; 4(5):575-88. PubMed ID: 20932143 [TBL] [Abstract][Full Text] [Related]
16. Thiopurine methyltransferase and thiopurine metabolite testing in patients with inflammatory bowel disease who are taking thiopurine drugs. Sheffield LJ; Irving P; Gupta A; Byron K; Macrae FA; Phillimore H; Dronavalli M; Rose R; George P; Walmsley T; Dixon B; Poole S; Dooley M; Sparrow M Pharmacogenomics; 2009 Jul; 10(7):1091-9. PubMed ID: 19604082 [TBL] [Abstract][Full Text] [Related]
17. [Pharmacogenetic study of thiopurine S-methyltransferase (TPMT) and thiopurine toxicity]. Corominas H; Díaz C; Vázquez G; Baiget M Rev Esp Enferm Dig; 2002 Oct; 94(10):635-6. PubMed ID: 12647415 [No Abstract] [Full Text] [Related]
18. The effect of allopurinol and low-dose thiopurine combination therapy on the activity of three pivotal thiopurine metabolizing enzymes: results from a prospective pharmacological study. Seinen ML; van Asseldonk DP; de Boer NK; Losekoot N; Smid K; Mulder CJ; Bouma G; Peters GJ; van Bodegraven AA J Crohns Colitis; 2013 Nov; 7(10):812-9. PubMed ID: 23317929 [TBL] [Abstract][Full Text] [Related]
19. Review article: recent advances in pharmacogenetics and pharmacokinetics for safe and effective thiopurine therapy in inflammatory bowel disease. Moon W; Loftus EV Aliment Pharmacol Ther; 2016 Apr; 43(8):863-883. PubMed ID: 26876431 [TBL] [Abstract][Full Text] [Related]
20. Successful Pregnancies with Thiopurine-Allopurinol Co-Therapy for Inflammatory Bowel Disease. Sheikh M; Nelson-Piercy C; Duley J; Florin T; Ansari A J Crohns Colitis; 2015 Aug; 9(8):680-4. PubMed ID: 25939351 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]